A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia.
Aslostovar L, Boyd AL, Almakadi M, Collins TJ, Leong DP, Tirona RG, Kim RB, Julian JA, Xenocostas A, Leber B, Levine MN, Foley R, Bhatia M.
Aslostovar L, et al. Among authors: tirona rg.
Blood Adv. 2018 Aug 14;2(15):1935-1945. doi: 10.1182/bloodadvances.2018015677.
Blood Adv. 2018.
PMID: 30093531
Free PMC article.
Clinical Trial.